Addex Therapeutics Ltd

ADXN | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.53

+$0.13 (+3.98%)

At close: Sep 21, 2026, 4:00 PM ET

$3.31

-$0.22 (-6.23%)

After-hours: Sep 21, 2026, 7:45 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	29.97K	404.1K	1.61M	1.42M	2.92M	3.61M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	29.97K	404.1K	1.61M	1.42M	2.92M	3.61M
Operating Income	-2.81M	-2.76M	-2.24M	-10.54M	-15.51M	-12.24M
Interest Income	n/a	9.17K	63.96K	29.25K	5.32K	35.31K
Pretax Income	-6.84M	-4.91M	-2.5M	-10.8M	-15.35M	-12.86M
Net Income	-6.73M	7.06M	-10.56M	-20.8M	-15.35M	-12.86M
Selling & General & Admin	1.89M	1.68M	2.03M	3.26M	7.75M	5.75M
Research & Development	190.19K	435.19K	942.71K	7.88M	9.01M	10.37M
Other Expenses	766.45K	1.05M	882.25K	817.79K	1.66M	-266.32K
Operating Expenses	2.84M	3.16M	3.86M	11.96M	18.42M	15.86M
Interest Expense	2.42K	3.55K	21.61K	48.9K	63.01K	69.5K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.84M	3.16M	3.86M	11.96M	18.42M	15.86M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	935K	817.61K	619.23K	376.54K	284.33K	222.35K
Shares Outstanding (Diluted)	935K	817.61K	619.23K	376.54K	284.33K	222.35K
EPS (Basic)	-6.88	8.40	-16.80	-55.20	-54	-57.60
EPS (Diluted)	-6.88	8.40	-16.80	-55.20	-54	-57.60
EBITDA	-6.83M	-4.65M	-2.19M	-10.45M	-14.94M	-12.41M
EBIT	-6.84M	-4.91M	-2.5M	-10.78M	-15.29M	-12.79M
Depreciation & Amortization	8.47K	260.12K	305.95K	323.14K	347.61K	378.75K